Healthcare Global Enterprises Ltd

Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Healthcare Global Enterprises Ltd

₹ 724 -2.57%
21 Nov - close price
hcgoncology.com BSE: 539787 NSE: HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 10,197 Cr.
  • Current Price ₹ 724
  • High / Low ₹ 805 / 456
  • Stock P/E 288
  • Book Value ₹ 65.3
  • Dividend Yield 0.00 %
  • ROCE 8.56 %
  • ROE 5.14 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 19.3% CAGR over last 5 years
  • Promoter holding has increased by 1.32% over last quarter.

Cons

  • Stock is trading at 11.1 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Tax rate seems low
  • Company has a low return on equity of 4.72% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.62%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
420 425 442 461 487 470 495 526 554 559 585 613 647
345 349 365 386 402 391 403 435 451 470 480 505 524
Operating Profit 75 76 76 74 85 79 92 91 102 88 106 108 123
OPM % 18% 18% 17% 16% 17% 17% 19% 17% 18% 16% 18% 18% 19%
2 4 5 3 3 6 9 9 11 6 10 8 3
Interest 26 27 26 26 27 29 27 34 36 41 44 45 44
Depreciation 41 41 42 41 43 44 46 47 50 57 58 58 63
Profit before tax 10 11 13 11 18 11 28 19 28 -3 14 12 20
Tax % 47% 63% 57% 65% 40% 69% 17% 28% 25% -335% 50% 50% -4%
5 4 6 4 11 3 23 14 21 8 7 6 21
EPS in Rs 0.53 0.54 0.60 0.55 0.97 0.41 1.53 0.87 1.29 0.50 0.53 0.34 1.15
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
451 519 584 700 829 976 1,092 1,009 1,395 1,691 1,908 2,218 2,404
413 443 499 595 713 864 936 887 1,161 1,394 1,581 1,835 1,979
Operating Profit 38 76 85 105 116 112 157 122 234 297 327 384 425
OPM % 9% 15% 15% 15% 14% 11% 14% 12% 17% 18% 17% 17% 18%
3 0 -2 10 25 10 10 -72 110 15 24 39 26
Interest 32 34 38 23 42 70 138 119 98 104 109 155 174
Depreciation 36 39 44 57 71 85 148 159 158 163 174 211 235
Profit before tax -27 3 0 35 27 -33 -119 -229 88 45 68 57 42
Tax % 20% -56% -730% 34% 38% -7% 5% -3% 56% 61% 39% 14%
-32 5 2 23 17 -31 -125 -221 39 18 41 49 41
EPS in Rs -5.21 0.12 -0.17 2.59 2.36 -2.82 -12.03 -15.43 3.87 2.11 3.46 3.19 2.52
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 16%
5 Years: 15%
3 Years: 17%
TTM: 18%
Compounded Profit Growth
10 Years: 52%
5 Years: 19%
3 Years: 73%
TTM: -35%
Stock Price CAGR
10 Years: %
5 Years: 38%
3 Years: 34%
1 Year: 55%
Return on Equity
10 Years: -1%
5 Years: 0%
3 Years: 5%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 68 70 85 86 87 88 89 125 139 139 139 139 141
Reserves 196 210 341 347 428 389 293 572 731 721 686 783 780
292 349 324 420 464 658 1,347 977 915 901 1,274 1,837 1,768
133 147 294 372 461 515 518 357 433 549 601 780 897
Total Liabilities 688 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,586
512 528 583 685 828 970 1,646 1,382 1,547 1,553 1,758 2,442 2,430
CWIP 11 42 121 148 174 153 46 30 22 18 83 25 96
Investments 2 0 64 11 53 49 34 26 9 10 10 11 13
164 205 275 381 385 478 520 593 641 730 850 1,062 1,048
Total Assets 688 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,586

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
51 60 73 91 98 98 130 121 220 252 285 317
-12 -79 -204 -210 -283 -238 -101 -171 125 -133 -226 -488
-27 22 216 89 161 84 -58 112 -155 -140 -64 -42
Net Cash Flow 13 2 85 -29 -24 -56 -30 62 190 -22 -5 -213

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 43 45 43 54 57 59 62 67 57 65 56 66
Inventory Days 33 36 32 40 46 45 35 32 31 33 33 33
Days Payable 193 208 264 272 274 303 234 221 199 214 216 210
Cash Conversion Cycle -117 -127 -188 -178 -171 -200 -136 -121 -112 -116 -127 -111
Working Capital Days -20 -65 -96 -112 -74 -110 -102 -26 -43 -40 -70 -91
ROCE % 1% 7% 6% 7% 6% 3% 1% -1% 5% 8% 9% 9%

Shareholding Pattern

Numbers in percentages

11 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
71.39% 71.37% 71.35% 71.30% 71.29% 71.28% 71.26% 71.23% 71.22% 71.22% 62.46% 63.78%
7.18% 6.37% 6.47% 6.29% 6.37% 6.74% 3.95% 4.30% 2.77% 2.44% 2.16% 3.59%
4.41% 5.53% 6.58% 7.94% 8.46% 8.52% 10.89% 11.64% 12.94% 12.48% 13.22% 18.36%
17.04% 16.71% 15.59% 14.49% 13.89% 13.45% 13.90% 12.84% 13.07% 13.86% 22.17% 14.28%
No. of Shareholders 28,70728,85825,93127,32727,28927,19526,52929,67032,82045,39447,02846,970

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls